MKRN2 and metastatic malignant neoplasm in the lymph nodes: Previous studies have reported that MKRN2 inhibits the cell migration and invasion of non-small cell lung cancer by downregulating the PI3K/Akt pathway and is associated with lymph node metastasis, TNM stage, and cell differentiation (7).